Patients with diabetes The GLP-1 mechanism for improving blood glucose and helping patients lose weight also has the potential to improve ocular disease, with some caveats
Common side effects include : Diarrhea Vomiting Stomach pain Upset stomach or indigestion Dizziness Burping Flatulence Stomach flu-like symptoms Heartburn or acid reflux Common cold-like symptoms Hypoglycemia (low blood sugar) in people with type 2 diabetes More serious side effects are also possible but are less likely
USA 75 , 23382342 (1978)
doi: 10.1016/j.eprac.2021.04.001 Summary Keywords semaglutide, overweight, obese, meta-analysis, subgroup Citation Zhang R, Hou Q, Li B, Deng L, Yang Y, Li T, Yao X, Yang L, Lin X, Liao Y, Wang L, Liu Y, Tan J, Wan Z and Shuai P (2023) Efficacy and safety of subcutaneous semaglutide in adults with overweight or obese: a subgroup meta-analysis of randomized controlled trials
Circulation , 150 (2), 151161